Original Research
Published on 02 Mar 2026
The protease inhibitor gabexate mesylate targets Raf kinase inhibitor protein and reverses epithelial–mesenchymal transition in triple-negative breast cancer cells
in Breast Cancer
- 215 views
Original Research
Published on 02 Mar 2026
in Breast Cancer
Original Research
Published on 02 Mar 2026
in Inflammation
Methods
Published on 02 Mar 2026
in Organizational Justice, Diversity, Equity, Inclusion, and Belonging
Original Research
Published on 02 Mar 2026
in Bone Research
Original Research
Published on 02 Mar 2026
in Ophthalmology
Policy Brief
Published on 02 Mar 2026
in Gender, Sex and Sexualities
Original Research
Published on 02 Mar 2026
in Clinical Diabetes
Systematic Review
Published on 02 Mar 2026
in Clinical Diabetes
Systematic Review
Published on 02 Mar 2026
in Public Health and Nutrition
Original Research
Published on 02 Mar 2026
in Clinical Diabetes
Systematic Review
Published on 02 Mar 2026
in Dementia and Neurodegenerative Diseases
Review
Published on 02 Mar 2026
in Neuro-Oncology and Neurosurgical Oncology
Review
Published on 02 Mar 2026
in Nutritional Immunology
Original Research
Published on 02 Mar 2026
in Oncology in Veterinary Medicine
Original Research
Published on 02 Mar 2026
in Cancer Endocrinology
Case Report
Published on 02 Mar 2026
in Gastrointestinal Cancers: Colorectal Cancer